Comparing Tests for Tuberculosis Diagnosis in The Gambia
Author Information
Author(s): Adetifa Ifedayo MO, Lugos Moses D, Hammond Abdulrahman, Jeffries David, Donkor Simon, Adegbola Richard A, Hill Philip C
Primary Institution: Bacterial Diseases Programme, Medical Research Council Laboratories, Fajara, The Gambia
Hypothesis
The performance of interferon gamma release assays (IGRAs) for diagnosing latent Mycobacterium tuberculosis infection may vary across populations and settings.
Conclusion
The ELISPOT test is more sensitive than the QFT-GIT for diagnosing TB disease, while both tests perform similarly in diagnosing latent TB infection.
Supporting Evidence
- The sensitivity of ELISPOT was 78.7% compared to 64.0% for QFT-GIT.
- Overall agreement between both IGRAs for LTBI in contacts was 71.4%.
- Significant discordance was found between the IGRAs and TST.
- Neither IGRA nor TST showed false positive results due to BCG vaccination.
Takeaway
This study looked at two tests to find out if someone has tuberculosis. One test worked better for finding active TB, while both tests were good for checking if someone might have been exposed to it.
Methodology
The study compared the sensitivity of ELISPOT and QFT-GIT tests in newly diagnosed TB cases and their household contacts, using blood samples and Mantoux skin tests.
Potential Biases
Potential misclassification bias due to the timing of the TST relative to the IGRAs.
Limitations
The study relied on the presence of a BCG scar for assessing vaccination status, which may not accurately reflect immunization history.
Participant Demographics
320 individuals were recruited, including 194 household contacts and 80 TB cases, with a majority of contacts being female and cases being male.
Statistical Information
P-Value
0.047
Confidence Interval
95% CI: 67.7–87.2% for ELISPOT; 95% CI: 51–73% for QFT-GIT
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website